UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019027
Receipt number R000022000
Scientific Title Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case
Date of disclosure of the study information 2015/09/15
Last modified on 2019/06/24 09:23:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case

Acronym

Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case

Scientific Title

Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case

Scientific Title:Acronym

Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case

Region

Japan


Condition

Condition

Massive hemorrhage by trauma, gastrointestinal hemorrhage

Classification by specialty

Surgery in general Gastrointestinal surgery Operative medicine
Emergency medicine Blood transfusion

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of the dosage of the concentrated fibrinogen preparation as supportive treatment for the patients who are expected that a large amount of blood transfusins are required because of massive hemorrage.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The amount of total blood tranfusion until hemostasis completion

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Term:28 weeks
infusion:Red cell concentrated 10units, ordinary blood transfusion concentrated fibrin preparation 3g

Interventions/Control_2

Term:28 weeks
infusion:Red cell concentrated 10units, ordinary blood transfusion

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.The man and woman who are 20 years or older.
2.The patients that doctor recognizes necessity of massive blood transfusin by MTP due to massive hemorrhage by injury and gastrointestinal bleeding.
3.The patients who are conveyed and admitted to emergency and critical care center, without tranferring to the other hospital and Obstetrics,
heart blood vessel sugeryy patient

Key exclusion criteria

1.Pregnant woman
2.Under 20 years old
3.Immunocompromised (state) patients
4.Patients with allegy for blood products
5.Patients who are diagnosed as congenital low fibrinogen blood symptom
6.the patient that informed consent is not provided
7.the patient who is dead during primary care treatment even MTP procedure was exercised or not given the treatment with RCC,FFP and the concentrated fibrin preparation.
8.the patient who cannot perform a blood test after dosage

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Otomo

Organization

Medical Hospital,Tokyo Medical and Dental University

Division name

Trauma and Acute Critical Care Medical Center

Zip code

113-8510

Address

1-5-45 Yushima Bunkyo-ku Tokyo

TEL

03-3813-6111

Email

otomo.accm@tmd.ac.jp


Public contact

Name of contact person

1st name Kiyoshi
Middle name
Last name Murata

Organization

Medical Hospital,Tokyo Medical and Dental University

Division name

Trauma and Acute Critical Care Medical Center

Zip code

113-8510

Address

1-5-45 Yushima Bunkyo-ku Tokyo

TEL

03-3813-6111

Homepage URL


Email

murata.acc@tmd.ac.jp


Sponsor or person

Institute

Trauma and Acute Critical Care Medical Center,Medical Hospital,Tokyo Medical and Dental Universitiy

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical and Dental University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Review Board TMDU Medical Hospitale

Address

1-5-45,Yushima, BUnkyo-ward,Tokyo,Japan

Tel

03-3813-6111

Email

03-3813-6111


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 10 Month 31 Day

Date of IRB

2013 Year 12 Month 17 Day

Anticipated trial start date

2014 Year 01 Month 10 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 09 Month 15 Day

Last modified on

2019 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022000